By Fisher, JD, CHC, CCEP
Recent Fraud Settlements Highlight Whistleblower and Compliance Risks for Health Care Providers
Health care compliance officers and counsel often review fraud settlements to identify the enforcement priorities receiving government attention. Although settlement announcements do not define the full scope of compliance risk, they provide useful insight into the types of arrangements, billing practices, and internal controls that federal regulators are scrutinizing.
Key Takeaways
- Recent False Claims Act settlements provide a practical guide to current enforcement priorities.
- Whistleblowers, including former employees and other insiders, continue to drive health care fraud investigations.
- Providers should review high-risk arrangements before concerns are raised externally, particularly in areas involving referrals, medical necessity, coding, and federal program reimbursement.
These enforcement developments are most useful when treated as a checklist for internal review. Providers should use recent settlements to test whether comparable risks exist in their own billing, referral, coding, and documentation practices, and to confirm that concerns are being escalated and resolved before they become external complaints.
For providers, these settlements offer a practical opportunity to compare the conduct alleged by the government against the organization’s own operations and determine whether similar risks may exist internally.
Whistleblower Risk and Enforcement Exposure
A related lesson is that many enforcement matters begin with whistleblower allegations. The False Claims Act permits private individuals with original information to bring qui tam lawsuits on behalf of the government and, if the case is successful, to share in the recovery. As a result, the potential universe of claimants is broad and may include employees, former employees, contractors, consultants, physicians, competitors, and others with knowledge of the challenged conduct.
Organizations should not assume that a whistleblower’s credibility or motives will control the outcome. Even a difficult or disgruntled source may have enough information to initiate a qui tam action and trigger a government investigation. Once that process begins, the focus typically shifts to the underlying facts, documentation, billing practices, and compliance controls.
For that reason, whistleblower risk should not be viewed solely as an employment issue. A complaint by someone with operational knowledge can expose practices that have continued for years. Even if the government declines to intervene, the organization may still face costly litigation, document preservation obligations, reputational harm, and operational disruption.
The recent volume of False Claims Act activity underscores this point. The Department of Justice reported that False Claims Act settlements and judgments exceeded $6.8 billion in fiscal year 2025, the highest annual total in the statute’s history, and that whistleblowers filed 1,297 qui tam lawsuits during that period. Health care matters continued to represent the largest share of recoveries, with enforcement attention directed toward managed care, prescription drug arrangements, medically unnecessary services, and other areas involving federal health care program reimbursement.
Practical Compliance Response
The practical response is straightforward: assume that questionable practices may eventually be reviewed by someone outside the organization. Internal concerns should be taken seriously, investigated promptly, and documented carefully. A disciplined compliance response can reduce the likelihood that an internal concern becomes an external whistleblower action and can strengthen the organization’s position if the government later asks questions.
Providers should also assess whether their compliance programs are identifying the same categories of risk reflected in recent enforcement actions. Priority areas include physician compensation, referral relationships, coding and billing practices, medical necessity documentation, marketing activities, patient assistance programs, and incentive arrangements that could be characterized as improper remuneration. Longstanding practices should not be assumed to be low risk; in some cases, they may increase exposure because the potential damages period is longer.
Recent Settlement Examples
Recent settlements illustrate how whistleblower complaints can surface operational practices that later become government enforcement priorities.
Medically unnecessary ambulance services. Courtesy Transport Services, LLC and its owners agreed to pay $900,000 to resolve allegations that they billed Medicare and Medicaid for non-emergency ambulance transportation that was not medically necessary or not actually provided. The case began with a qui tam complaint filed by a former employee, underscoring how billing practices that may appear routine internally can become the subject of a federal investigation when raised by someone with first-hand knowledge.
Hospice referral arrangements. Creative Hospice Care, Inc., affiliated entities, and Mahlega Abdsharafat paid $9.2 million to settle allegations that medical director arrangements were used to induce hospice patient referrals. According to the government, the investigation began with a whistleblower complaint from a former employee involved in marketing the company’s services. This settlement is a reminder that physician compensation and medical director arrangements should be reviewed not only for fair market value and commercial reasonableness, but also for whether compensation could be viewed as tied to referral volume or value.
Benefits to referring physicians. Community Health System and Physician Network Advantage Inc. agreed to pay $31.5 million to resolve allegations that they provided referring physicians with benefits such as meals, alcohol, cigars, electronic health record subsidies, and bonuses allegedly intended to induce referrals. The case demonstrates that remuneration risk is not limited to direct cash payments; perks, subsidies, technology support, and incentive payments may also create exposure if they are connected to referrals of federal health care program business.
Medicare Advantage diagnosis coding. Kaiser Permanente affiliates agreed to pay $556 million to resolve allegations that invalid diagnosis codes were submitted for Medicare Advantage enrollees to obtain higher payments. The government alleged that physicians were pressured to alter medical records after patient visits to add diagnoses that had not been considered or addressed during those visits. This settlement reflects the government’s continued focus on risk-adjustment data, medical record support, and internal coding practices in managed care.
Together, these matters show why settlement announcements are useful compliance tools. They identify conduct regulators are willing to pursue, show how insiders can bring issues to the government’s attention, and reinforce the need to document the compliance rationale for high-risk arrangements before they are challenged.
Compliance Recommendations
Health care organizations can reduce whistleblower and enforcement risk by taking the following compliance steps:
- Maintain accessible internal reporting channels, including anonymous options where appropriate, and reinforce that employees may raise concerns without fear of retaliation.
- Take complaints seriously regardless of the source. A concern raised by a former, difficult, or disgruntled employee may still identify conduct that warrants prompt review.
- Document each compliance review, including the concern raised, documents reviewed, personnel interviewed, findings reached, corrective action taken, and the rationale for closing the matter.
- Conduct periodic audits of high-risk areas, including medical necessity, coding and billing, Medicare Advantage risk adjustment, physician compensation, referral relationships, marketing practices, and patient assistance arrangements.
- Review physician contracts, medical director agreements, co-management arrangements, technology subsidies, and other benefits to referral sources for fair market value, commercial reasonableness, and Anti-Kickback Statute or Stark Law risk.
- Train managers, billing personnel, coding teams, and business development staff to recognize and escalate potential False Claims Act issues before they become external complaints.
- Involve legal counsel promptly when a concern may implicate federal health care program reimbursement, repayment obligations, whistleblower allegations, or potential self-disclosure considerations.
The False Claims Act’s whistleblower provisions remain a significant driver of health care fraud enforcement. Providers that proactively identify, investigate, document, and correct compliance concerns are better positioned to manage risk before a whistleblower frames the issue for the government.
